SCHEMBL8565612

SCHEMBL8565612

Nc1ccc(Sc2ccnc3cc(C(F)(F)F)ccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
ADRB2 P07550 1/20 0.42
NCF1 P14598 1/20 0.42
NOS3 P29474 1/20 0.41
NOS2 P35228 1/20 0.41
DHFR P00374 1/20 0.40
PARP1 P09874 1/20 0.40
KIF11 P52732 3/20 0.39
KDR P35968 2/20 0.39
DYRK1A Q13627 2/20 0.39
GAK O14976 1/20 0.39
EGFR P00533 1/20 0.38
GRM4 Q14833 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
PDE7A Q13946 1/20 0.38
PLK4 O00444 1/20 0.37
DYRK3 O43781 1/20 0.37
PRKD3 O94806 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565482 0.84 ADRB2 (0.42) MEN1ALDH1A1KMT2AADRB2NCF1
SCHEMBL9024092 0.77 ADRB2 (0.48) ADRB2NCF1NOS3NOS2PARP1
SCHEMBL7488303 0.75 KDM1A (0.54) MEN1KMT2ANCF1DHFRKDR
SCHEMBL1980284 0.75 NR4A2 (0.56) ADRB2NCF1NOS3NOS2PARP1
SCHEMBL7809666 0.73 ADRB2 (0.36) ALDH1A1ADRB2NCF1PARP1KIF11
SCHEMBL7809674 0.73 TDP1 (0.40) ALDH1A1ADRB2NCF1KDRDYRK1A
SCHEMBL27619316 0.72 GRM4 (0.44) ADRB2NCF1NOS3NOS2PARP1
SCHEMBL4419333 0.71 RAC1 (0.48) KMT2AADRB2NCF1NOS3NOS2
SCHEMBL5050795 0.71 PDGFRA (0.61) KDREGFR
SCHEMBL4167757 0.70 RAC1 (0.54) ADRB2NCF1NOS3NOS2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5814646-A TREATING THE PROGRESSION OF ALZHEIMER'S DISEASE, BRAIN DISORDERS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
US-5624937-A TREATMENT OF ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1997-04-29 US disclosed